๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice

โœ Scribed by William R. Waud; Jacqueline Plowman; Steadman D. Harrison; Donald J. Dykes; Wayne K. Anderson; Daniel P. Griswold

Publisher
Springer
Year
1992
Tongue
English
Weight
682 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Imatinib mesylate potentiates topotecan
Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models
โœ Heather P. McDowell; Daniela Meco; Anna Riccardi; Barbara Tanno; Anna C. Berardi ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 331 KB

## Abstract High levels of PDGFR expression in primary rhabdomyosarcoma (RMS) have been associated with disease progression. To date however, there are no reports on the activity of imatinib mesylate, a selective PDGFR inhibitor, in RMS preclinical models. A panel of 5 RMS cell lines was used to in